Author | Robert Dreicer, MD | OncLive

Author | Robert Dreicer, MD

Articles

Dr. Dreicer on Response to Immunotherapy in Urothelial Cancer

September 06, 2019

Robert Dreicer, MD, deputy director, UVA Cancer Center, director, Solid Tumor Oncology in the Division of Hematology/Oncology, and a professor of Medicine and Urology, University of Virginia Health System, discusses response to immunotherapy in urothelial cancer.

Dr. Dreicer on Biomarkers of Response to Immunotherapy in Urothelial Cancer

April 05, 2019

Robert Dreicer, MD, professor of medicine and urology, University of Virginia Health System, section chief, Medical Oncology, deputy director, UVA Cancer Center, discusses biomarkers of response to immunotherapy in patients with metastatic urothelial cancer.

Dr. Dreicer on Ongoing Trials in Prostate Cancer

July 19, 2017

Robert Dreicer, MD, professor, University of Virginia Health System, discusses ongoing trials investigating emerging treatments for patients with prostate cancer.

Dr. Dreicer on the Current Role of Abiraterone and Enzalutamide in Prostate Cancer

April 11, 2017

Robert Dreicer, MD, professor, University of Virginia Health System, discusses the current role of abiraterone acetate (Zytiga) and enzalutamide (Xtandi) for patients with prostate cancer.

x